Dibact (250+31.25) Injection | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
Dibact (250+31.25) Injection
Dibact (250+31.25) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Inspira (Svizera Healthcare) (Maneesh Pharmaceuticals Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ceftriaxone, Tazobactam. This drug comes in the form of Injection. The general packing available for this medicine consists of 1 Vial and is priced at Rs 39.5 (arround $0.553 US Dollar)| Generic (Salt) Combination : | (Ceftriaxone+ Tazobactam) |
| Pharma Company : | Inspira (Svizera Healthcare) (Maneesh Pharmaceuticals Ltd) |
| Brand Label : | Dibact (250+31.25) |
| Preparation Type : | Injection |
| Single Dose : | 1 Vial |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 1 Vial |
| Price Unit : | Rs 39.5 INR (arround $0.553 US Dollar) |
| Price Pack : | Rs 39.5 INR (arround $0.553 US Dollar) |
Drug details for Dibact (250+31.25)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Dibact (250+31.25) are :
Ceftriaxone
Indication (Prescribed for or used as): Meningitis, septicaemia, typhoid, UTI, proplylaxis in surgical infections.
For more details on Ceftriaxone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ceftriaxone..
TazobactamIndication (Prescribed for or used as): Infections caused by Pseudomonas or Klebsiella in neutropenic/immunocompromised patients. Mixed
For more details on Tazobactam, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Tazobactam..
Dibact (250+31.25) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 36 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Dibact (250+31.25), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ceftriaxone-250 mg Tazobactam-31.25 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.